SouthState’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
SouthState's KRYS Position: Q3 2026 in Review
SouthState sold out of Krystal Biotech (KRYS) in Q3 2026, closing a stake of 2 shares — an estimated $744 sold.
SouthState first reported a position in KRYS in Q2 2026 and held it in 1 quarter. The position peaked at $744 in Q2 2026. 353 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- SouthState reported no remaining Krystal Biotech position as of Q3 2026 after selling out during the quarter.
- SouthState sold 2 Krystal Biotech shares in Q3 2026, an estimated $744.
- SouthState first reported a position in Krystal Biotech in Q2 2026 and held it in 1 quarter.
- SouthState's Krystal Biotech position peaked at $744 in Q2 2026.
- 353 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.